Branston Steven D, Wright Jason, Keshavarz-Moore Eli
Department of Biochemical Engineering, The Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, Bernard Katz Building, Gordon Street, London, WC1H 0AH, UK.
NeuroPhage Pharmaceuticals, 222 Third Street, Suite 3120, Cambridge, Massachusetts, 02142.
Biotechnol Bioeng. 2015 Aug;112(8):1714-9. doi: 10.1002/bit.25571. Epub 2015 May 5.
The Ff filamentous bacteriophages show potential as a new class of therapeutics, displaying utility in materials science as well as pharmaceutical applications. These phages are produced by the infection of E. coli, a Gram-negative bacterium which unavoidably sheds endotoxins into the extracellular space during growth. Since endotoxin molecules are highly immunoreactive, separation from the phage product is of critical importance, particularly those developed for human therapeutic use. The properties of M13, one of the Ff group, present a purification challenge chiefly because the standard scalable method for endotoxin removal from proteins-anion exchange chromatography-is not applicable due to pI similarity between the particles. This article examines the potential of polyethylene glycol (PEG)-NaCl precipitation as a scalable method for the separation of endotoxins from phage M13. Precipitation of M13 by 2% (w/v) PEG 6 000, 500 mM NaCl reduced endotoxin contamination of the phage product by 88%, but additional precipitation rounds did not maintain this proportional decrease. Dynamic light scattering was subsequently used to determine the effectiveness of a detergent to disassociate endotoxin molecules from M13. As a result, PEG-NaCl precipitation was supplemented with up to 2% (v/v) Triton X-100 to improve separation. A 5.7 log10 reduction in endotoxin concentration was achieved over three rounds of precipitation whilst retaining over 97% of the phage. This method compares favorably with the well-known ATPS (Triton X-114) technique for endotoxin removal from protein solutions.
Ff丝状噬菌体作为一类新型治疗剂具有潜力,在材料科学以及药物应用中都有实用价值。这些噬菌体是通过感染大肠杆菌产生的,大肠杆菌是一种革兰氏阴性菌,在生长过程中不可避免地会将内毒素释放到细胞外空间。由于内毒素分子具有高度免疫反应性,从噬菌体产物中分离内毒素至关重要,尤其是对于那些用于人类治疗用途的噬菌体。Ff噬菌体组中的M13的特性带来了纯化挑战,主要是因为从蛋白质中去除内毒素的标准可扩展方法——阴离子交换色谱法——由于颗粒之间的等电点相似性而不适用。本文研究了聚乙二醇(PEG)-氯化钠沉淀法作为从噬菌体M13中分离内毒素的可扩展方法的潜力。用2%(w/v)PEG 6000、500 mM氯化钠沉淀M13可使噬菌体产物的内毒素污染降低88%,但额外的沉淀轮次并未保持这种比例下降。随后使用动态光散射来确定一种去污剂将内毒素分子与M13解离的有效性。结果,在PEG-氯化钠沉淀中添加高达2%(v/v)的 Triton X-100以改善分离效果。经过三轮沉淀,内毒素浓度降低了5.7个对数单位,同时保留了超过97%的噬菌体。该方法与从蛋白质溶液中去除内毒素的著名的ATPS(Triton X-114)技术相比具有优势。